Glucocorticoids and oxidative stress.
Glucocorticoids (GC) are used widely for the treatment of patients with various disorders, including autoimmune diseases, allergies, and lymphoproliferative disorders. Glucocorticoid therapy is often limited by several adverse reactions associated with GC excess. Excess GC can elicit a variety of symptoms and signs, including growth retardation in children; immunosuppression; cardiovascular disorders like hypertension and atherosclerosis; osteoporosis; myopathy; and diabetes mellitus. Currently, attention is focused on oxidative stress as one of the major determinants of endothelial dysfunction and cardiovascular senescence. The main reason for all unwanted effects of GC is that dexamethasone induces the overproduction of reactive oxygen species, causing dysregulation of physiological processes. Humans and animals with GC-induced hypertension exhibit reduced nitric oxide levels; patients with excess GC levels also suffer from depression as a consequence of low levels of serotonin and melatonin. The common cofactor for the production of these vasoactive molecules is tetrahydrobiopterin (BH4), which is required for nitric oxide synthesis.
Bjelaković
G
G
Institute of Biochemistry, CC Nis, Faculty of Medicine, University of Nisg, Nis, Serbia. bjelakovic@junis.ni.ac.yu
Beninati
S
S
Pavlović
D
D
Kocić
G
G
Jevtović
T
T
Kamenov
B
B
Saranac
L J
LJ
Bjelaković
B
B
Stojanović
I
I
Basić
J
J
D000818:Animals; D001708:Biopterins / Q000031:analogs & derivatives; D003907:Dexamethasone / Q000009:adverse effects / Q000494:pharmacology; D005938:Glucocorticoids / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D009569:Nitric Oxide / Q000096:biosynthesis / Q000378:metabolism; D018384:Oxidative Stress / Q000187:drug effects*; D017382:Reactive Oxygen Species / Q000378:metabolism
D005938:Glucocorticoids; D017382:Reactive Oxygen Species; D001708:Biopterins; D009569:Nitric Oxide; D003907:Dexamethasone; C003402:sapropterin